Cholesterol Depletion‐Enhanced Ferroptosis and Immunotherapy via Engineered Nanozyme
Open Access
- 9 August 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (38) , e2405826
Abstract
Ferroptosis, an iron‐ and reactive oxygen species (ROS)‐dependent cell death, holds significant promise for tumor therapy due to its ability to induce lipid peroxidation (LPO) and trigger antitumor immune responses. However, elevated cholesterol levels in cancer cells impede ferroptosis and compromise immune function. Here, a novel nanozyme, Fe‐MOF/CP, composed of iron metal‐organic framework (Fe‐MOF) nanoparticles loaded with cholesterol oxidase and PEGylation for integrated ferroptosis and immunotherapy is introduced. Fe‐MOF/CP depletes cholesterol and generates hydrogen peroxide, enhancing ROS levels and inducing LPO, thereby promoting ferroptosis. This process disrupts lipid raft integrity and downregulates glutathione peroxidase 4 and ferroptosis suppressor protein 1, further facilitating ferroptosis. Concurrently, Fe‐MOF/CP augments immunogenic cell death, reduces programmed death‐ligand 1 expression, and revitalizes exhausted CD8+ T cells. In vivo studies demonstrate significant therapeutic efficacy in abscopal, metastasis, and recurrent tumor models, highlighting the robust antitumor immune responses elicited by Fe‐MOF/CP. This study underscores the potential of Fe‐MOF/CP as a multifunctional therapeutic agent that combines ferroptosis and immunotherapy, offering a promising strategy for effective and durable cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (32201153, 62275048)
This publication has 47 references indexed in Scilit:
- Multi‐Enzyme Co‐Expressed Nanomedicine for Anti‐Metastasis Tumor Therapy by Up‐Regulating Cellular Oxidative Stress and Depleting CholesterolAdvanced Materials, 2023
- An AND Logic Gate for Magnetic‐Resonance‐Imaging‐Guided Ferroptosis Therapy of TumorsAdvanced Materials, 2023
- A Cholesterol Metabolic Regulated Hydrogen‐Bonded Organic Framework (HOF)‐Based Biotuner for Antibody Non‐Dependent Immunotherapy Tailored for GlioblastomaAdvanced Materials, 2023
- Targeted Therapy of Oral Squamous Cell Carcinoma with Cancer Cell Membrane Coated Co‐Fc Nanoparticles Via Autophagy InhibitionAdvanced Functional Materials, 2023
- Amplification of Lipid Peroxidation by Regulating Cell Membrane Unsaturation To Enhance Chemodynamic TherapyAngewandte Chemie, 2023
- Robust Dual Enzyme Cascade‐Catalytic Cholesterol Depletion for Reverse Tumor Multidrug ResistanceAdvanced Healthcare Materials, 2022
- Ferroptosis in cancer and cancer immunotherapyCancer Communications, 2022
- Exploration of nanozymes in viral diagnosis and therapyExploration, 2022
- Improving Cancer Immunotherapy Outcomes Using BiomaterialsAngewandte Chemie, 2020
- Recent Progress in Ferroptosis Inducers for Cancer TherapyAdvanced Materials, 2019